Krystal Biotech, Inc. KRYS Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s net change in cash?
- Krystal Biotech, Inc. (KRYS) reported net change in cash of $5.01M in Q1 2026.
- How has Krystal Biotech, Inc.'s net change in cash changed year-over-year?
- Krystal Biotech, Inc.'s net change in cash increased by 113.9% year-over-year, from -$36.1M to $5.01M.
- What is the long-term trend for Krystal Biotech, Inc.'s net change in cash?
- Over 3 years (2022 to 2025), Krystal Biotech, Inc.'s net change in cash has grown at a -5.5% compound annual growth rate (CAGR), from -$179.35M to $151.44M.
- What does net change in cash mean?
- The total change in the company's cash balance during the period.
- How do you interpret net change in cash?
- A positive change indicates net cash generation, while a negative change indicates cash consumption.
- How does net change in cash compare across companies?
- A critical metric for biotech companies to assess their cash runway and financial sustainability.